🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12443+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12443 recruiting trials

RecruitingNCT05575024

Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy With oXiris Membrane

👨‍⚕️ Seung Seok Han, M.D., Seoul National University Hospital📍 1 site📅 Started Jan 2024View details ↗
RecruitingNCT07007832

Bile Omics for Diagnosing Indeterminate Biliary Strictures

👨‍⚕️ Xueying Ding, MD, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06233526

Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test

👨‍⚕️ Xiaojun Xu, MD, The Children's Hospital of Zhejiang University School of Medicine📍 1 site📅 Started Jan 2024View details ↗
NARecruitingNCT06196567

Pulsed Electromagnetic Field Therapy on Muscle Strength and Function in Patients With End-stage of Knee Osteoarthritis

👨‍⚕️ Michael Tim-Yun Ong, Chinese University of Hong Kong📍 1 site📅 Started Jan 2024View details ↗
Phase 3RecruitingNCT06079879

A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

👨‍⚕️ Medical Director, Merck Sharp & Dohme LLC📍 161 sites📅 Started Dec 2023View details ↗
Phase 1, PHASE2RecruitingNCT06109558

The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC

👨‍⚕️ Nong Yang, MD, Hunan Cancer Hospital📍 1 site📅 Started Dec 2023View details ↗
Phase 1RecruitingNCT06180174

Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma

👨‍⚕️ Yuqin Song, M.D, Peking University Cancer Hospital & Institute📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT05457829

Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of First Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study

👨‍⚕️ Yizhuo Zhang, PhD, Sun Yat-sen University📍 1 site📅 Started Dec 2023View details ↗
Phase 2, PHASE3RecruitingNCT07459790

The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions

🏥 JSC NextGen📍 1 site📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT06170489

A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)

🏥 Shanghai Junshi Bioscience Co., Ltd.📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT06168851

Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)

👨‍⚕️ Lei Zhang, MD, Chinese Academy of Medical Science and Blood Disease Hospital📍 1 site📅 Started Dec 2023View details ↗
Phase 1, PHASE2RecruitingNCT06279741

Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants

👨‍⚕️ Beatrice De Vos, M.D., Ph.D., EXO Biologics SA📍 8 sites📅 Started Dec 2023View details ↗
RecruitingNCT06002607

Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections

👨‍⚕️ Areg Grigorian, MD, University of California, Irvine📍 1 site📅 Started Dec 2023View details ↗
Phase 3RecruitingNCT06247085

A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care Treatment

👨‍⚕️ Michael Imperiale, MD, Travere Therapeutics, Inc.📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT06220552

The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma

🏥 Fifth Affiliated Hospital, Sun Yat-Sen University📍 1 site📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT07019220

Chemoablation for Low-Grade Bladder Cancer

👨‍⚕️ Shahrokh F. Shariat Prof. Dr., Professor, Department of Urology, Medical University of Viernna📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06008691

A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice

👨‍⚕️ Marco Ladetto, Prof., AO SS Antonio e Biagio e Cesare Arrigo, Alessandria📍 61 sites📅 Started Dec 2023View details ↗
Phase 2RecruitingNCT06010329

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

🏥 Teligene US📍 9 sites📅 Started Dec 2023View details ↗
NARecruitingNCT06314477

Effect of CPAP Treatment in Patients With Severe Uncontrolled Asthma: The ASTHMA-SLEEP Trial

👨‍⚕️ Mireia Dalmases, MD, Hospital Clinic📍 1 site📅 Started Dec 2023View details ↗
RecruitingNCT06402318

Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine

👨‍⚕️ Tony Yuan, PhD, Uniformed Services University of the Health Sciences (USUHS)📍 1 site📅 Started Dec 2023View details ↗
← PreviousPage 347 of 623Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →